Karol Watson, MD, and Steven Nissen, MD: Liraglutide on Cardiovascular Risk

Karol Watson, MD, and Steven Nissen, MD spoke with MD Magazine about Liraglutide and it's effects on lowering cardiovascular risk. The FDA reviewed Liraglutide on Aug. 25, 2017.